Research

New discoveries in lung cancer research, such as the research funded by LCFA, are resulting in new treatments for lung cancer patients

How LCFA uses your donation wisely to fight lung cancer:

You Make A Donation to LCFA
Your dollars are added to contributions from other donors




We maximize your donation by adding it to dollars from LCFA’s strategic funding partners.


This leveraged donation allows LCFA to award a generous grant to a top young lung cancer investigator for 2 years of focused and intense research.


The lung cancer investigator
can now start the critical two-year process of research and discovery

Now, armed with this new evidence, the lung cancer investigator presents their findings to organizations like the National Institutes of Health (NIH) for consideration for vital next-stage grants.

Each painstaking step brings us closer to understanding how lung cancer works, how to detect it earlier, how to fight it better, and – someday – how to cure it.



Latest In Research

01/2
2019

Patients now living a median 6.8 years after stage IV ALK+ lung cancer diagnosis

from EurekAlert University of Colorado Study Patients now living a median 6.8 years: According to the National Cancer Institute, patients diagnosed with non-small cell lung cancer (NSCLC) between the years 1995 and 2001 had 15 percent chan…

01/2
2019

Lung Cancer Deaths are 28 Percent Lower in California

From UC San Diego Health State’s long-term, aggressive tobacco control programs cited as primary reason Early adoption of tobacco control efforts in California led to fewer people ever smoking, reduced the amount used by those who do smok…

01/2
2019

First-Line Immunotherapy Combo Fails to Improve Survival in Lung Cancer Trial

From Specialty Pharmacy Times Clinical Trial results: First-line immunotherapy combo fails: New study shows that first-line immunotherapy that uses durvalumab (Imfinzi, AstraZeneca) or the combination of durvalumab and tremelimumab failed t…

12/8
2018

FDA Approves Atezolizumab Combination

from Business Wire FDA Approves Atezolizumab in Combination Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approvedatezolizumab (Tecentriq®), in combination with Avastin® (bevac…

12/8
2018

Policy changes needed for access to lung cancer treatments

from The Hill Advances in Lung Cancer Treatment Advances in treatment have completely transformed the way that Americans are living with lung cancer, something that was unthinkable even ten years ago. Since 2015, the U.S. Food and Drug Ad…

12/5
2018

New DNA sequencing test credited with saving his life

from The Boston Globe I was only given months to live four years ago . . . I am still thriving John White, a retired North Attleborough bioengineer, was diagnosed in early 2015 with aggressive prostate cancer. It had spread to his bladder a…

10/23
2018

Personalized Medicine for NTRK Fusion-Positive Solid Tumors

From Market Watch: Personalized Medicine Entrectinib Shrank Tumors in People with NTRK Fusion-Positive Solid Tumors Entrectinib showed response irrespective of tumor type or spread to the central nervous system. Data will be submitted to …

10/17
2018

Women with lung cancer live longer than men

From Helio: Women with newly diagnosed stage I to stage III non-small cell lung cancer (NSCLC) appeared to have longer overall survival than their male counterparts, according to results of a trial presented at International Association …

10/17
2018

After Decades, New Standard of Care in Small Cell Lung Cancer

From Medscape: For the first time in decades, overall survival has been shown to improve in patients with extensive-stage small cell lung cancer (ES-SCLC) when concurrent immunotherapy is added to standard chemotherapy in the first-line set…

10/9
2018

Can body fluids help spot lung cancer?

From US News Blood, saliva and even breath may one day be able to diagnose lung cancer. Lung Cancer is the no. 1 cancer killer in the U.S. "In fact, it kills more people than the next top three cancers combined," which are colorectal, brea…



Read More